Skip to main content

Research Repository

Advanced Search

MicroRNA-511-3p Mediated Modulation of the Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Controls LPS-Induced Inflammatory Responses in Human Monocyte Derived DCs

Awuah, Dennis; Ruisinger, Alisa; Alobaid, Meshal; Mbadugha, Chidimma; Ghaemmaghami, Amir M.

MicroRNA-511-3p Mediated Modulation of the Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Controls LPS-Induced Inflammatory Responses in Human Monocyte Derived DCs Thumbnail


Authors

Dennis Awuah

Alisa Ruisinger

Meshal Alobaid

Chidimma Mbadugha



Abstract

Abstract: The peroxisome proliferator-activated receptor gamma (PPAR) is a ligand-activated transcription factor expressed in dendritic cells (DCs), where it exerts anti-inflammatory responses against TLR4-induced inflammation. Recently, microRNA-511 (miR 511) has also emerged as a key player in controlling TLR4-mediated signalling and in regulating the function of DCs. Interestingly, PPAR
has been previously highlighted as a putative target of miR-511 activity; however, the link between miR-511 and PPAR and its influence on human DC function within the context of LPS-induced
inflammatory responses is unknown. Using a selection of miR-511-3p-specific inhibitors and mimics, we demonstrate for the first time that knockdown or overexpression of miR-511-3p inversely correlates with PPAR mRNA levels and affects its transcriptional activity following treatment with rosiglitazone (RSG; PPAR
agonist), in the presence or absence of LPS. Additionally, we show that PPAR-mediated suppression of DC activation and pro-inflammatory cytokine production in miR-511-3p knockdown DCs is abrogated following overexpression of miR-511-3p. Lastly, PPAR
activation suppressed LPS-mediated induction of indoleamine 2,3-dioxygenase (IDO) activity in DCs, most likely due to changes in miR-511-3p expression. Our data thus suggests that PPAR-induced modulation of DC phenotype and function is influenced by miR-511 3p expression, which may serve as a potential therapeutic target against inflammatory diseases.

Journal Article Type Article
Acceptance Date Jan 11, 2022
Online Publication Date Jan 14, 2022
Publication Date Jan 14, 2022
Deposit Date Feb 17, 2022
Publicly Available Date Feb 17, 2022
Journal Immuno
Print ISSN 2673-5601
Electronic ISSN 2673-5601
Publisher MDPI AG
Peer Reviewed Peer Reviewed
Volume 2
Issue 1
Pages 104-117
DOI https://doi.org/10.3390/immuno2010008
Keywords dendritic cells; miR-511-3p; RNAi; PPAR ; inflammation; indoleamine 2,3 dioxygenase; immune modulation
Public URL https://nottingham-repository.worktribe.com/output/7471698
Publisher URL https://www.mdpi.com/2673-5601/2/1/8

Files





You might also like



Downloadable Citations